EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Experimental and Statistical Studies in the Development of Ketoprofen–Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Application in Compressed Tablets

Monica Stamate Cretan, Lacramioara Ochiuz, Camelia-Elena Iurciuc-Tincu, Carmen Anatolia Gafițanu, Alexandra Barsan (Bujor), Mousa Sha’at, Ciprian Stamate

Macromol · 05.08.2026 · 6 (3) · 58

DOI: 10.3390/macromol6030058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromol, online erschienen am 05.08.2026. Verfasst von Monica Stamate Cretan und 6 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketoprofen is a Biopharmaceutics Classification System (BCS) class II non-steroidal anti-inflammatory drug whose therapeutic performance is limited by its poor aqueous solubility, though complexation with cyclodextrins is a well-established strategy to overcome this limitation. The aim of this work was to prepare and characterize inclusion complexes of ketoprofen with HPβCD. Complexes were obtained by the solution (magnetic-stirring) method at ketoprofen–HPβCD molar ratios of 1:1 and 2:1 and were characterized by Fourier-transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) coupled with EDX, and computer-assisted dimensional analysis and statistics (AutoCAD/MathCAD). The bulk and tapped densities were used to derive the Carr index and the Hausner ratio, respectively. FT-IR showed attenuation and shifting of the characteristic C=O, C=C, and –CH bands of ketoprofen and the presence of the 1655 cm−1 band in complexes demonstrates inclusion. DSC revealed a marked reduction of the ketoprofen melting endotherm, the degree of inclusion reaching 75% (1:1) and 62% (2:1). SEM and statistical analysis confirm, individualized particles, predominantly 20–100 µm in perimeter size. The dissolution test showed a faster release of the complexes than in the case of pure ketoprofen. Therefore, HPβCD forms stable inclusion complexes with ketoprofen having pharmacotechnical properties suitable for compressed tablets.

Zitieren

APA

Cretan, M. S., Ochiuz, L., Iurciuc-Tincu, C., Gafițanu, C. A., (Bujor), A. B., Sha’at, M., & Stamate, C. (2026). Experimental and Statistical Studies in the Development of Ketoprofen–Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Application in Compressed Tablets. Macromol, 6(3), 58. https://doi.org/10.3390/macromol6030058

Vancouver

Cretan MS, Ochiuz L, Iurciuc-Tincu C, Gafițanu CA, (Bujor) AB, Sha’at M, et al. Experimental and Statistical Studies in the Development of Ketoprofen–Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Application in Compressed Tablets. Macromol. 2026;6(3):58. doi:10.3390/macromol6030058

BibTeX
@article{Cretan2026,
  author = {Cretan, Monica Stamate and Ochiuz, Lacramioara and Iurciuc-Tincu, Camelia-Elena and Gafițanu, Carmen Anatolia and (Bujor), Alexandra Barsan and Sha’at, Mousa and Stamate, Ciprian},
  title = {Experimental and Statistical Studies in the Development of Ketoprofen–Hydroxypropyl-β-Cyclodextrin Inclusion Complexes for Application in Compressed Tablets},
  journal = {Macromol},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {58},
  doi = {10.3390/macromol6030058}
}
Kostenlos starten →